AVAH Stock — Aveanna Healthcare Holdings Inc

Aveanna Healthcare Holdings Inc (AVAH)

Updated October 16, 2026.

AVAH is a Stock. Total return is 2.8% over the past 5.5 years, 94.0 points behind SPY at 96.8%.

Aveanna Healthcare Holdings Inc. is a diversified home care platform company providing pediatric and adult healthcare services across three segments: private duty nursing and therapy services, home health and hospice care, and enteral nutrition supplies and products. The company does not currently have an established distribution schedule. This stock appeals to investors seeking exposure to the home healthcare sector.

AVAH performance versus SPY

Price and return data through 2026-10-16.

Total return is 2.8% over the past 5.5 years, 94.0 points behind SPY at 96.8%. Over the past year its total return — price change plus distributions reinvested — is 23.5%. Its deepest 1-year drawdown was 39.4%.

AVAH key facts

Asset type

Stock

Asset class

Equity

Inception date

04/28/2021

Distribution frequency

None

Last close

$12.34 (as of 2026-10-16)

Market cap

$2,693,707,028

Average volume

1365226.0

Beta

1.949

Payout ratio

0.0%

P/E ratio

9.79

Forward P/E

13.3156

EPS

$1.26

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

AVAH risks and drawbacks

Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 39.4%.

Who may consider AVAH — and who may not

It is a weaker fit for investors who need monthly cash flow (AVAH does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.

More on AVAH

• All tickers starting with A

Tagged: Healthcare.

Frequently asked questions